INS and type 2 diabetes mellitus: In a clinical mechanistic study of individuals with T2D, glucose-stimulated insulin secretion, evaluated using an intravenous glucose load and a subsequent hyperglycemic clamp, was increased by treatment with empagliflozin, and a further increase was obtained after the addition of linagliptin [84].